Works matching IS 20458932 AND DT 2022 AND VI 12 AND IP 3
Results: 42
Association between income and likelihood of right heart catheterization in individuals with pulmonary hypertension: A US claims database analysis.
- Published in:
- Pulmonary Circulation, 2022, v. 12, n. 3, p. 1, doi. 10.1002/pul2.12132
- By:
- Publication type:
- Article
A pilot study to examine association of BMI with functional class and 6 min walk distance in idiopathic and heritable PAH: Possible association with estrogen metabolism.
- Published in:
- Pulmonary Circulation, 2022, v. 12, n. 3, p. 1, doi. 10.1002/pul2.12139
- By:
- Publication type:
- Article
Symptom phenotypes in pulmonary arterial hypertension: The PAH "symptome".
- Published in:
- Pulmonary Circulation, 2022, v. 12, n. 3, p. 1, doi. 10.1002/pul2.12135
- By:
- Publication type:
- Article
Using a knowledge translation program to facilitate guideline‐ and evidence‐based patient management: the PAH‐QuERI Extension Program.
- Published in:
- Pulmonary Circulation, 2022, v. 12, n. 3, p. 1, doi. 10.1002/pul2.12134
- By:
- Publication type:
- Article
Riociguat in children with pulmonary arterial hypertension: The PATENT–CHILD study.
- Published in:
- Pulmonary Circulation, 2022, v. 12, n. 3, p. 1, doi. 10.1002/pul2.12133
- By:
- Publication type:
- Article
Social determinants of health in pulmonary arterial hypertension patients in the United States: Clinician perspective and health policy implications.
- Published in:
- Pulmonary Circulation, 2022, v. 12, n. 3, p. 1, doi. 10.1002/pul2.12111
- By:
- Publication type:
- Article
The traditional Chinese patented medicine Qingke Pingchuan granules alleviate acute lung injury by regenerating club cells.
- Published in:
- Pulmonary Circulation, 2022, v. 12, n. 3, p. 1, doi. 10.1002/pul2.12138
- By:
- Publication type:
- Article
On errata and corrigenda—The Pulmonary Hypertension Association Registry (PHAR).
- Published in:
- 2022
- By:
- Publication type:
- Correction Notice
Comparison between thermodilution and Fick methods for resting and exercise‐induced cardiac output measurement in patients with chronic dyspnea.
- Published in:
- Pulmonary Circulation, 2022, v. 12, n. 3, p. 1, doi. 10.1002/pul2.12128
- By:
- Publication type:
- Article
Clinical significance of pulmonary hypertension in interstitial lung disease: A consensus statement from the Pulmonary Vascular Research Institute's innovative drug development initiative—Group 3 pulmonary hypertension.
- Published in:
- Pulmonary Circulation, 2022, v. 12, n. 3, p. 1, doi. 10.1002/pul2.12127
- By:
- Publication type:
- Article
Real‐world use of inhaled treprostinil for lung disease‐pulmonary hypertension: A protocol for patient evaluation and prescribing.
- Published in:
- Pulmonary Circulation, 2022, v. 12, n. 3, p. 1, doi. 10.1002/pul2.12126
- By:
- Publication type:
- Article
Elucidating tricuspid Doppler signal interpolation and its implication for assessing pulmonary hypertension.
- Published in:
- Pulmonary Circulation, 2022, v. 12, n. 3, p. 1, doi. 10.1002/pul2.12125
- By:
- Publication type:
- Article
The impact of the COVID‐19 pandemic on the care of pulmonary hypertension patients outside the Hubei province in China.
- Published in:
- Pulmonary Circulation, 2022, v. 12, n. 3, p. 1, doi. 10.1002/pul2.12130
- By:
- Publication type:
- Article
Exploring the failing right ventricle in pulmonary hypertension by cardiac magnetic resonance: An in vivo study utilizing Macitentan.
- Published in:
- Pulmonary Circulation, 2022, v. 12, n. 3, p. 1, doi. 10.1002/pul2.12124
- By:
- Publication type:
- Article
"Baicalin prevents pulmonary arterial remodeling in vivo via the AKT/ERK/NF‐κB signaling pathways".
- Published in:
- 2022
- By:
- Publication type:
- Correction Notice
Factors determining change in treatment for ambulatory children with pulmonary arterial hypertension: Implications for monitoring.
- Published in:
- Pulmonary Circulation, 2022, v. 12, n. 3, p. 1, doi. 10.1002/pul2.12121
- By:
- Publication type:
- Article
Prediction of patient outcomes through social determinants of health: The Pulmonary Hypertension Association Registry (PHAR) evaluation.
- Published in:
- Pulmonary Circulation, 2022, v. 12, n. 3, p. 1, doi. 10.1002/pul2.12120
- By:
- Publication type:
- Article
INSPIRE: Safety and tolerability of inhaled Yutrepia (treprostinil) in pulmonary arterial hypertension (PAH).
- Published in:
- Pulmonary Circulation, 2022, v. 12, n. 3, p. 1, doi. 10.1002/pul2.12119
- By:
- Publication type:
- Article
Pulmonary Vascular Research Institute GoDeep: A meta‐registry merging deep phenotyping datafrom international PH reference centers.
- Published in:
- Pulmonary Circulation, 2022, v. 12, n. 3, p. 1, doi. 10.1002/pul2.12123
- By:
- Publication type:
- Article
Balloon pulmonary angioplasty for patients with chronic thromboembolic pulmonary hypertension previously operated by pulmonary endarterectomy.
- Published in:
- 2022
- By:
- Publication type:
- Case Study
Prevalence of potential drug–drug interactions with disease‐specific treatments in patients with pulmonary arterial hypertension or chronic thromboembolic pulmonary hypertension: A registry study.
- Published in:
- Pulmonary Circulation, 2022, v. 12, n. 3, p. 1, doi. 10.1002/pul2.12114
- By:
- Publication type:
- Article
Pulmonary thromboembolic events in COVID‐19—A systematic literature review.
- Published in:
- Pulmonary Circulation, 2022, v. 12, n. 3, p. 1, doi. 10.1002/pul2.12113
- By:
- Publication type:
- Article
ERRATUM.
- Published in:
- 2022
- Publication type:
- Correction Notice
Prevalence of aortic stenosis and TAVR outcomes in patients with systemic sclerosis‐associated pulmonary hypertension.
- Published in:
- Pulmonary Circulation, 2022, v. 12, n. 3, p. 1, doi. 10.1002/pul2.12118
- By:
- Publication type:
- Article
Direct oral anticoagulants in patients with chronic thromboembolic pulmonary hypertension and the presence of recent thrombus during pulmonary endarterectomy.
- Published in:
- Pulmonary Circulation, 2022, v. 12, n. 3, p. 1, doi. 10.1002/pul2.12110
- By:
- Publication type:
- Article
The 6th International Leh Symposium.
- Published in:
- Pulmonary Circulation, 2022, v. 12, n. 3, p. 1, doi. 10.1002/pul2.12109
- Publication type:
- Article
Persistence of persistent pulmonary hypertension of the newborn: A case of de novo TBX4 variant.
- Published in:
- 2022
- By:
- Publication type:
- Case Study
l‐Carnitine therapy improves right heart dysfunction through Cpt1‐dependent fatty acid oxidation.
- Published in:
- Pulmonary Circulation, 2022, v. 12, n. 3, p. 1, doi. 10.1002/pul2.12107
- By:
- Publication type:
- Article
Clinical application of risk assessment in PAH: Expert center APRN recommendations.
- Published in:
- Pulmonary Circulation, 2022, v. 12, n. 3, p. 1, doi. 10.1002/pul2.12106
- By:
- Publication type:
- Article
The role of macrophages in right ventricular remodeling in experimental pulmonary hypertension.
- Published in:
- Pulmonary Circulation, 2022, v. 12, n. 3, p. 1, doi. 10.1002/pul2.12105
- By:
- Publication type:
- Article
Abnormal platelet aggregation in pediatric pulmonary hypertension.
- Published in:
- Pulmonary Circulation, 2022, v. 12, n. 3, p. 1, doi. 10.1002/pul2.12104
- By:
- Publication type:
- Article
The role of exercise right heart catheterization to guide pulmonary hypertension therapy in older adults.
- Published in:
- Pulmonary Circulation, 2022, v. 12, n. 3, p. 1, doi. 10.1002/pul2.12103
- By:
- Publication type:
- Article
A simpler noninvasive method of predicting markedly elevated pulmonary vascular resistance in patients with chronic thromboembolic pulmonary hypertension.
- Published in:
- Pulmonary Circulation, 2022, v. 12, n. 3, p. 1, doi. 10.1002/pul2.12102
- By:
- Publication type:
- Article
Pirfenidone ameliorates pulmonary arterial pressure and neointimal remodeling in experimental pulmonary arterial hypertension by suppressing NLRP3 inflammasome activation.
- Published in:
- Pulmonary Circulation, 2022, v. 12, n. 3, p. 1, doi. 10.1002/pul2.12101
- By:
- Publication type:
- Article
Caveolin‐1 associated with severe (pediatric‐onset) presentation of pulmonary arterial hypertension.
- Published in:
- Pulmonary Circulation, 2022, v. 12, n. 3, p. 1, doi. 10.1002/pul2.12100
- By:
- Publication type:
- Article
Pulmonary artery enlargement predicts poor survival in patients with COPD: A meta‐analysis.
- Published in:
- Pulmonary Circulation, 2022, v. 12, n. 3, p. 1, doi. 10.1002/pul2.12099
- By:
- Publication type:
- Article
Apolipoprotein A1 is associated with pulmonary vascular resistance and adverse clinical outcomes in patients with pulmonary hypertension secondary to heart failure.
- Published in:
- Pulmonary Circulation, 2022, v. 12, n. 3, p. 1, doi. 10.1002/pul2.12096
- By:
- Publication type:
- Article
Clinically important changes in right ventricular volume and function in pulmonary arterial hypertension assessed with cardiac magnetic resonance imaging.
- Published in:
- Pulmonary Circulation, 2022, v. 12, n. 3, p. 1, doi. 10.1002/pul2.12097
- By:
- Publication type:
- Article
When you hear hoofbeats, think zebras – pulmonary veno‐occlusive disease: A case report.
- Published in:
- 2022
- By:
- Publication type:
- Case Study
Impact of COVID‐19 lockdown on exercise capacity in PAH patients.
- Published in:
- Pulmonary Circulation, 2022, v. 12, n. 3, p. 1, doi. 10.1002/pul2.12089
- By:
- Publication type:
- Article
The hemodynamic characteristics of severe chronic lung disease referred for lung transplantation.
- Published in:
- Pulmonary Circulation, 2022, v. 12, n. 3, p. 1, doi. 10.1002/pul2.12082
- By:
- Publication type:
- Article
The comparative effects of sacubitril/valsartan versus enalapril on pulmonary hypertension due to heart failure with a reduced ejection fraction.
- Published in:
- Pulmonary Circulation, 2022, v. 12, n. 3, p. 1, doi. 10.1002/pul2.12034
- By:
- Publication type:
- Article